Anal Hpv Infection

A proof-of-concept trial revealed that GA2, a second-generation vaccine candidate that uses genetically attenuated malaria parasites, prevented 89% of participants who received it from being infected with malaria.

Anal high-risk HPV and abnormal cytology were common among transgender women regardless of their age, HIV status and/or hormone use, researchers determined.